 |
answer text |
<p>The Medicines and Healthcare products Regulatory Agency (MHRA) continuously monitors
the safety of all medicines on the market in the United Kingdom. Following a recent
European review of the available epidemiological data on the risk of neurodevelopmental
disorders with use of paracetamol in pregnancy, the product information for paracetamol
is already being updated to reflect the findings.</p><p>The MHRA has sought independent
advice from its expert committees on this latest study which found an increased risk
of neurocognitive effects in children born to women who took paracetamol during pregnancy.
The expert committees advised that the new study adds to the existing body of evidence
but does not provide any further insight into a possible causal association between
in utero exposure to paracetamol and neurodevelopmental outcomes.</p><p>Patients should
be advised that if necessary, paracetamol can be used during pregnancy. However, it
should be used at the lowest possible dose that reduces symptoms and for the shortest
time possible.</p><p>Pregnant women should speak to their doctor or midwife before
taking any medicine, including paracetamol.</p><p> </p><p> </p><p> </p>
|
|
